| __timestamp | ADMA Biologics, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 504755000 |
| Thursday, January 1, 2015 | 6745968 | 838526000 |
| Friday, January 1, 2016 | 8494742 | 1177697000 |
| Sunday, January 1, 2017 | 18092835 | 1320433000 |
| Monday, January 1, 2018 | 22502922 | 1556200000 |
| Tuesday, January 1, 2019 | 25910757 | 1834800000 |
| Wednesday, January 1, 2020 | 35050817 | 1346000000 |
| Friday, January 1, 2021 | 42896889 | 1824900000 |
| Saturday, January 1, 2022 | 52458024 | 2115900000 |
| Sunday, January 1, 2023 | 59020000 | 2631300000 |
| Monday, January 1, 2024 | 2954400000 |
Unlocking the unknown
In the competitive world of biotechnology, understanding spending patterns can reveal much about a company's strategic priorities. Over the past decade, Regeneron Pharmaceuticals, Inc. and ADMA Biologics, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Regeneron's SG&A expenses surged by over 400%, peaking at approximately $2.63 billion in 2023. This reflects their aggressive expansion and investment in marketing and administrative capabilities. In contrast, ADMA Biologics, while smaller in scale, demonstrated a consistent upward trend, with SG&A expenses increasing nearly 12-fold, reaching around $59 million in 2023. This growth underscores ADMA's commitment to scaling operations and enhancing market presence. These spending patterns not only highlight the companies' growth strategies but also provide insights into their market positioning and future potential.
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs ADMA Biologics, Inc.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Summit Therapeutics Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc. Trends and Insights
Regeneron Pharmaceuticals, Inc. vs Axsome Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Regeneron Pharmaceuticals, Inc. and Cytokinetics, Incorporated
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Regeneron Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
ADMA Biologics, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: ADMA Biologics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights